Back

Effects of levosimendan therapy in patients with severe functional mitral regurgitation and chronic heart failure undergoing mitraclip implantation: a single-centre experience

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Mitral Valve Interventions Mitral valve interventions ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Francesca Fiorelli

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
MitraClip implantation as effective symptomatic therapy of dynamic mitral regurgitation unraveled by handgrip echocardiography.
Associate Professor M. Spieker (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Echocardiographic predictors for a single vs. multiclip strategy in percutaneous mitral valve repair
Doctor B. Goebel (Bad Berka, DE)
Abstract
Presentation thumbnail
In patients with end stage functional mitral regurgitation, mitral annulus geometry is independent on the ischemic or non-ischemic etiology of left ventricular dysfunction
Doctor N. Ruozi (Reggio Nell'Emilia, IT)
Abstract Slides
Presentation thumbnail
Spherical ventricle, large left atrium size and anemia predict 1-year failure of MitraClip therapy in patients with functional mitral regurgitation
Doctor K. Hellhammer (Duesseldorf, DE)
Abstract
Presentation thumbnail
Impact of post-procedural mitral stenosis on long-term outcome in high-surgical risk patients treated successfully by MitraClip implantation
Doctor D. Kalbacher (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Mitral Valve Interventions

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources